Melbourne, Australia-based imaging agent developer Telix has reached a deal to acquire RLS (USA) Inc. for up to $250 million, the two announced. RLS operates America’s only Joint Commission-accredited radiopharmacy network, with 31 locations covering over 85% of the U.S. population. Headquartered in Lake Mary, Florida, RLS distributes PET and SPECT agents along with therapeutic radiopharmaceuticals, serving over 1,500 customers. Telix said the acquisition aligns with its investment strategy of vertically integrating its supply chain, manufacturing and distribution. The deal will significantly expand its North American footprint and establish a “next generation” production operation to benefit Telix and its strategic commercial partners.
Read the full article: Imaging Agent Developer Telix to Buy RLS Radiopharmaceutical Network for up to $250M //
Source: https://radiologybusiness.com/topics/healthcare-management/mergers-and-acquisitions/imaging-agent-developer-telix-buy-rls-radiopharmaceutical-network-250m